Related references
Note: Only part of the references are listed.A systematic review of the effects of cannabis on cognition in people with multiple sclerosis
Jeffrey Landrigan et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
Yuyu Zhu et al.
ACTA PHARMACEUTICA SINICA B (2022)
CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ+CD8+T Cells and Modest Inhibition of Neuroinflammation
James M. Nichols et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)
Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System
Maria Chountoulesi et al.
BRAIN SCIENCES (2020)
Glucose metabolism links astroglial mitochondria to cannabinoid effects
Daniel Jimenez-Blasco et al.
NATURE (2020)
CBD and THC: Do They Complement Each Other Like Yin and Yang?
Sarah D. Pennypacker et al.
PHARMACOTHERAPY (2020)
Neurological, physical and sociodemographic correlates of employment in multiple sclerosis: A meta-analysis
Larissa Gerhard et al.
JOURNAL OF HEALTH PSYCHOLOGY (2020)
Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies
Jacqueline C. Duperrouzel et al.
JOURNAL OF DUAL DIAGNOSIS (2020)
Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
Jolana Markova et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2019)
Positive and Negative Effects of Cannabis and Cannabinoids on Health
Koby Cohen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies
Valentina Lorenzetti et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
Martina Absinta et al.
JAMA NEUROLOGY (2019)
Combination of Cannabinoids, Δ9-Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
Zinah Zamil Al-Ghezi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis
Xiaoming Yang et al.
SCIENTIFIC REPORTS (2019)
Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system
Ryan R. Wyrofsky et al.
NEUROBIOLOGY OF STRESS (2019)
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development
Heidi C. Meyer et al.
NEUROPSYCHOPHARMACOLOGY (2018)
The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study
Lanfranco Pellesi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis
M. Sorosina et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Localization of the cannabinoid type-1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus
Ana Gutierrez-Rodriguez et al.
GLIA (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Viewpoints: how the hippocampus contributes to memory, navigation and cognition
John Lisman et al.
NATURE NEUROSCIENCE (2017)
Cannabis use, attitudes, and legal status in the US: A review
Hannah Carliner et al.
PREVENTIVE MEDICINE (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Cannabinoid Modulation of the Stressed Hippocampus
Franciele F. Scarante et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Altered attentional control strategies but spared executive functioning in chronic cannabis users
Amy T. Nusbaum et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics
Melissa E. Badowski
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review
Samantha J. Broyd et al.
BIOLOGICAL PSYCHIATRY (2016)
Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes
Xingxing Diao et al.
FORENSIC TOXICOLOGY (2016)
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
F. Patti et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray
Giovanna Squintani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
A cannabinoid link between mitochondria and memory
Etienne Hebert-Chatelain et al.
NATURE (2016)
Keep off the grass? Cannabis, cognition and addiction
H. Valerie Curran et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults
Florian Ganzer et al.
NEUROPSYCHOLOGY REVIEW (2016)
Dissecting the cannabinergic control of behavior: The where matters
Arnau Busquets-Garcia et al.
BIOESSAYS (2015)
Cannabis and adolescent brain development
Dan I. Lubman et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction
Michael Loureiro et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Baby Boomers and Cannabis Delivery Systems
Fiona Murphy et al.
JOURNAL OF DRUG ISSUES (2015)
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
Stephen M. Stout et al.
DRUG METABOLISM REVIEWS (2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Nabiximols (THC/CBD Oromucosal Spray, Sativex (R)) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
Peter Flachenecker et al.
EUROPEAN NEUROLOGY (2014)
Neurocognition in college-aged daily marijuana users
Mary P. Becker et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2014)
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations
Simon A. Broadley et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2014)
Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures
Kora-Mareen Buehler et al.
MOLECULAR GENETICS AND GENOMICS (2014)
Adverse Health Effects of Marijuana Use
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal A Randomized Clinical Trial
David J. Allsop et al.
JAMA PSYCHIATRY (2014)
Political and Medical Views on Medical Marijuana and its Future
Muni Rubens
SOCIAL WORK IN PUBLIC HEALTH (2014)
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
Ewa Kozela et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
COMT val158met and 5-HTTLPR Genetic Polymorphisms Moderate Executive Control in Cannabis Users
Antonio Verdejo-Garcia et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Comprehensive Analysis of UGT1A1 Genetic Polymorphisms in Chinese Tibetan and Han Populations
Xiaoqing Zhang et al.
BIOCHEMICAL GENETICS (2012)
Linkage Analysis Followed by Association Show NRG1 Associated with Cannabis Dependence in African Americans
Shizhong Han et al.
BIOLOGICAL PSYCHIATRY (2012)
Neuropsychological deficits associated with cannabis use in young adults
Jon E. Grant et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Motivational and cognitive inhibitory control in recreational cannabis users
Merel F. H. Griffith-Lendering et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2012)
Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders
Raul Gonzalez et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2012)
CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells
Jonathon C. Arnold et al.
PHARMACOLOGICAL REPORTS (2012)
Cannabidiol in Humans-The Quest for Therapeutic Targets
Simon Zhornitsky et al.
PHARMACEUTICALS (2012)
C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2
D. A. de Luis et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Does cannabis use affect prospective memory in young adults?
Janice Bartholomew et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor
Alex Carrasquer et al.
PHARMACOGENETICS AND GENOMICS (2010)
Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells
Donna A. Whyte et al.
PHARMACOLOGY (2010)
Long-term effects of cannabis on eye movement control in reading
Lynn Huestegge et al.
PSYCHOPHARMACOLOGY (2010)
Control of mitochondrial transport and localization in neurons
Andrew F. MacAskill et al.
TRENDS IN CELL BIOLOGY (2010)
Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level
Olivier Harismendy et al.
GENOME BIOLOGY (2010)
Evidence for Association Between Polymorphisms in the Cannabinoid Receptor 1 (CNR1) Gene and Cannabis Dependence
Arpana Agrawal et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults
Christie A. Hartman et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Pharmacological and Therapeutic Secrets of Plant and Brain (Endo) Cannabinoids
Lumir Ondrej Hanus
MEDICINAL RESEARCH REVIEWS (2009)
Mitochondria in Neuroplasticity and Neurological Disorders
Mark P. Mattson et al.
NEURON (2008)
Endocannabinoid system and its implications for obesity and cardiometabolic risk
Richard W. Nesto et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2008)
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
Mellar P. Davis
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
The origin and application of experimental autoimmune encephalomyelitis
Alan G. Baxter
NATURE REVIEWS IMMUNOLOGY (2007)
TRP channels as novel players in the pathogenesis and therapy of itch
Tamds Biro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
Katarzyna Maresz et al.
NATURE MEDICINE (2007)
Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain
Somsak Mitrirattanakul et al.
PAIN (2006)
CB1 receptor antagonism increases hippocampal acetylcholine release:: Site and mechanism of action
Aldemar Degroot et al.
MOLECULAR PHARMACOLOGY (2006)
Association of GABRA2 with drug dependence in the collaborative study of the genetics of alcoholism sample
Arpana Agrawal et al.
BEHAVIOR GENETICS (2006)
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
S Walther et al.
PSYCHOPHARMACOLOGY (2006)
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
JC Ashton et al.
NEUROSCIENCE LETTERS (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
An investigation of human and rat liver microsomal mycophenolic acid glucuronidation: Evidence for a principal role of UGT1A enzymes and species differences in UGT1A specificity
KK Miles et al.
DRUG METABOLISM AND DISPOSITION (2005)
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
DJ Rog et al.
NEUROLOGY (2005)
Endocannabinoid control of food intake and energy balance
V Di Marzo et al.
NATURE NEUROSCIENCE (2005)
Human cannabinoid receptor 1:: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse
PW Zhang et al.
MOLECULAR PSYCHIATRY (2004)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs
L Villeneuve et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients
H Jinno et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
DT Wade et al.
CLINICAL REHABILITATION (2003)
Pharmacokinetics of THC in brain and testis, male gametotoxicity and premature apoptosis of spermatozoa
GG Nahas et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2002)
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: A pilot study
KA Sieradzan et al.
NEUROLOGY (2001)
Genetic susceptibility to adverse effects of drugs and environmental toxicants - The role of the CYP family of enzymes
M Ingelman-Sundberg
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis
A Achiron et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
